SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Arterial Vascular Engineering AVEI
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bullw who wrote ()8/10/1998 11:36:00 AM
From: Sam Armstrong  Read Replies (1) of 410
 
From Briefing.com:

11:00 -- 12:00 ET (Updated throughout the hour)******

Arterial Vascular Engineering Inc. (AVEI) 39 7/8 unch: Stephens Inc. upgrades designer and manufacturer of of highly specialized stent systems and percutaneous transluminal coronary angioplasty balloon catheters from "neutral" to "outperform" and raises its price target from $53.07 to $55.20 a share; soon to be acquired coronary catheter lab business from CR Bard will likely lower AVEI by as much as $0.25 a share in FY99; therefore, lowers FY99 EPS from $3.14 to $2.91 a share; gross profit margins will fall from 82% to 72%, while operating margins will decline from 48% to 36%; however, stock could appreciate by 42% as acquisition puts AVEI in a strong stent position.....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News